Inventor

Stefan Petry

Inventor
Frankfurt am Main, DE

Overview

38→
Patents
2002–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 38 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds28%
A61KPreparations for medical, dental or toiletry purposes17%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
C07CAcyclic or carbocyclic compounds4%
B82YSpecific uses or applications of nanostructures3%
C07KPeptides3%
H01LSemiconductor devices3%
H10DInorganic electric semiconductor devices3%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
PatentTitleYear
11,090,364Conjugates of a pharmaceutical agent and a moiety capable of binding to a glucose sensing protein20219,966,443Nanopillar field-effect and junction transistors with functionalized gate and base electrodes20189,960,238Nanopillar field-effect and junction transistors with functionalized gate and base electrodes20189,070,733'Nanopillar field-effect and junction transistors with functionalized gate and base electrodes'20159,029,400'5-oxoisoxazoles as inhibitors of lipases and phospholipases'20158,933,024'Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases'20158,921,404'Azole derivatives in the form of lipase and phospholipase inhibitors'20148,735,437'Imidazolidine carboxamide derivatives as lipase and phospholipase inhibitors'20148,357,698'Diacyl indazole derivatives as lipase and phospholipase inhibitors'20138,148,395'Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases'20128,008,331'Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors'20117,968,719'Indazole derivatives as inhibitors of hormone sensitive lipase'20117,897,616'Imidazopyridin-2-one derivatives as inhibitors of lipases and phospholipases'20117,897,625'Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases'20117,846,943'Azolopyridin-2-one derivatives as lipase and phospholipase inhibitors'20107,781,613'Substituted N-aminomethylene sulfonamides, production and use thereof as medicaments'20107,772,268'Diacyl indazole derivatives as lipase and phospholipase inhibitors'20107,741,491'Diphenylamine-substituted salicylthiazole derivatives and related compounds as phosphotyrosine phosphatase 1B (PTB1B) inhibitors for using as blood-sugar decreasing active ingredients for treating diabetes'20107,737,144'Pyrimido[5,4-e][1,2,4]triazine-5-7-diones, processes for preparing them and their use'20107,718,669'Triazolopyridine derivatives as inhibitors of lipases and phospholipases'20107,709,513'Benzooxazol-2-one derivatives as lipase and phospholipase inhibitors'20107,528,155'Indazole derivatives as inhibitors of hormone sensitive lipase'20097,453,009'Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use'20087,453,000'Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof'20087,449,560'Phosophoinositoglycan binding proteins'20087,211,592'Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom'20077,208,504'Bicyclic inhibitors of hormone sensitive lipase'20077,094,794'Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use'20067,049,416'Phosophoinositoglycan binding proteins'20066,900,233'Substituted 3-phenyl-5-alkoxy-3H-(1,3,4)-oxadiazol-2-ones, pharmaceutical composition and method for treating obesity thereof'20056,783,949'Processes for determining whether a test substance contains lipases or lipase inhibitors'20046,596,742'Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use in medicaments'20036,573,288'Substituted sulphonyl cyanamides, method for producing same and their use as medicament'20036,566,390'Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom'20036,372,917'Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them'20026,369,088'Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals'20026,369,236'Imidazole derivatives with biphenylsulfonyl substitution method for preparing them and their use as a drug or diagnostic agent'20026,369,069'Biphenylsulfonyl cyanamides, method for the production thereof and their utilization as a medicament'2002

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2002–2005Patents assigned to AVENTIS PHARMA GMBH (9)· patent assignee history
2002–2021Based in Frankfurt am Main, DE· patent location history
2006–2011Patents assigned to SANOFI AVENTIS DEUTSCHLAND (11)· patent assignee history
2006–2013Based in Kelkheim, DE· patent location history
2010–2012Patents assigned to SANOFI AVENTIS (9)· patent assignee history
2012–2015Patents assigned to PETRY STEFAN (6)· patent assignee history
2013–2021Patents assigned to SANOFI SA (9)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
SANOFI AVENTIS DEUTSCHLAND112006–2011
AVENTIS PHARMA GMBH92002–2005
SANOFI AVENTIS92010–2012
SANOFI SA92013–2021
PETRY STEFANself62012–2015
Locations
LocationPatentsSpan
Frankfurt am Main, DE302002–2021
Kelkheim, DE82006–2013